Combinations of therapeutic agents for treating cancer

Details for Australian Patent Application No. 2011202702 (hide)

Owner Novartis AG

Inventors Burke, Gregory; Linnartz, Ronald Richard; Versace, Richard William; Lane, Heidi

Agent Davies Collison Cave

Pub. Number AU-A-2011202702

Parent 2007240548

Filing date 1 June 2011

Wipo publication date 30 June 2011

International Classifications

A61K 31/132 (2006.01) - having two or more amino groups, e.g. spermidine, putrescine

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/282 (2006.01)

A61K 31/436 (2006.01)

A61K 31/437 (2006.01)

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/573 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/704 (2006.01)

A61K 31/7068 (2006.01)

A61K 31/7076 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

23 June 2011 Complete Application Filed

30 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202702

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202706-Bathroom fittings

2011202694-Hair styling